chitosan has been researched along with Endoleak in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Alturkistani, H; Bertrand-Grenier, A; Bhatnagar, S; Cloutier, G; Lerouge, S; Roy-Cardinal, MH; Sivakumaran, L; Soulez, G; Thérasse, É; Zehtabi, F | 1 |
| Annabi, B; Djerir, D; Ispas-Szabo, P; Lerouge, S; Mateescu, MA; Sivakumaran, L; Soulez, G; Zehtabi, F | 1 |
| Bertrand-Grenier, A; Dumont-Mackay, V; Fatimi, A; Héon, H; Lerouge, S; Soulez, G; Zehtabi, F | 1 |
1 trial(s) available for chitosan and Endoleak
| Article | Year |
|---|---|
Strain Ultrasound Elastography of Aneurysm Sac Content after Randomized Endoleak Embolization with Sclerosing vs. Non-sclerosing Chitosan-based Hydrogels in a Canine Model.
Topics: Animals; Chitosan; Dogs; Elasticity Imaging Techniques; Embolization, Therapeutic; Endoleak; Hydrogels; Retrospective Studies; Sodium Tetradecyl Sulfate; Thrombosis; Treatment Outcome | 2022 |
2 other study(ies) available for chitosan and Endoleak
| Article | Year |
|---|---|
Chitosan-doxycycline hydrogel: An MMP inhibitor/sclerosing embolizing agent as a new approach to endoleak prevention and treatment after endovascular aneurysm repair.
Topics: Animals; Aortic Aneurysm, Abdominal; Cell Line, Tumor; Chitosan; Dogs; Doxycycline; Endoleak; Gelatinases; Human Umbilical Vein Endothelial Cells; Humans; Protease Inhibitors; Sclerosing Solutions | 2017 |
Chitosan-Sodium Tetradecyl Sulfate Hydrogel: Characterization and Preclinical Evaluation of a Novel Sclerosing Embolizing Agent for the Treatment of Endoleaks.
Topics: Animals; Chitosan; Disease Models, Animal; Dogs; Embolization, Therapeutic; Endoleak; Endovascular Procedures; Hydrogels; Sclerosing Solutions; Sodium Tetradecyl Sulfate | 2017 |